Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
XB-PHENO-16592
Farley-Barnes KI et al. (2020)
|
Xtr + pax9 MO
NF18-19 (in situ hybridization)
|
|
|
|
Fig. 4C col3, G
Schwenty-Lara J et al. (2020)
|
Xla Wt + kmt2d MO
NF 17-18
|
|
|
|
Fig. 4C col4, G
Schwenty-Lara J et al. (2020)
|
Xla Wt + kmt2d MO
NF 17-18
|
|
|
|
Fig. 1 l
Ma P et al. (2017)
|
Xla Wt + zc4h2 MO
NF18 (Other Detection Assay)
|
|
|
|
Fig. 1 j
Ma P et al. (2017)
|
Xla Wt + zc4h2 MO
NF18 (whole-mount microscopy)
|
|
|
|
fig.3.c
Devotta A et al. (2016)
|
Xla Wt + sf3b4 MO
NF15 (in situ hybridization)
|
|
|
|
fig.4.c
Devotta A et al. (2016)
|
Xla Wt + sf3b4 MO
NF15 (in situ hybridization)
|
|
|
|
Fig.5 E
Gouignard N et al. (2016)
|
Xla Wt + dse MO
NF20 (in situ hybridization)
|
|
Ehlers-Danlos syndrome
|
|
fig.6.a
Macrì S et al. (2016)
|
Xla Wt + hmga2 + msx1
NF16 (in situ hybridization)
|
|
|
|
fig.6.b
Macrì S et al. (2016)
|
Xla Wt + hmga2 + pax3
NF16 (in situ hybridization)
|
|
|